Wellington Management Group LLP Sells 303,107 Shares of agilon health, inc. (NYSE:AGL)

Wellington Management Group LLP cut its position in shares of agilon health, inc. (NYSE:AGL - Free Report) by 0.6% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 52,579,488 shares of the company's stock after selling 303,107 shares during the quarter. Wellington Management Group LLP owned about 12.75% of agilon health worth $99,901,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Oak Thistle LLC bought a new stake in shares of agilon health during the 4th quarter valued at $25,000. Ieq Capital LLC purchased a new stake in agilon health in the fourth quarter worth about $26,000. Signaturefd LLC increased its stake in shares of agilon health by 143.0% during the fourth quarter. Signaturefd LLC now owns 14,388 shares of the company's stock valued at $27,000 after purchasing an additional 8,467 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. purchased a new position in shares of agilon health during the third quarter valued at approximately $28,000. Finally, Raymond James Financial Inc. bought a new stake in shares of agilon health in the 4th quarter worth approximately $33,000.

agilon health Stock Performance

Shares of AGL stock traded up $1.18 during mid-day trading on Tuesday, reaching $5.43. 10,676,559 shares of the company's stock traded hands, compared to its average volume of 5,557,447. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. The firm has a market capitalization of $2.24 billion, a PE ratio of -5.77 and a beta of 0.38. agilon health, inc. has a 12 month low of $1.50 and a 12 month high of $7.73. The firm has a 50 day moving average price of $3.76 and a two-hundred day moving average price of $2.99.

Remove Ads

Wall Street Analyst Weigh In

A number of brokerages have issued reports on AGL. Royal Bank of Canada lifted their price objective on agilon health from $3.00 to $3.50 and gave the company an "outperform" rating in a research note on Wednesday, February 26th. Needham & Company LLC restated a "hold" rating on shares of agilon health in a research note on Friday, March 21st. Citigroup raised agilon health from a "sell" rating to a "neutral" rating and increased their price objective for the company from $1.75 to $2.25 in a research report on Friday, January 10th. Stifel Nicolaus boosted their target price on agilon health from $2.00 to $3.00 and gave the stock a "hold" rating in a research report on Wednesday, February 26th. Finally, Macquarie started coverage on shares of agilon health in a report on Monday, December 16th. They set a "neutral" rating and a $3.00 price objective for the company. Two research analysts have rated the stock with a sell rating, twelve have issued a hold rating and three have given a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Hold" and a consensus target price of $4.37.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.